This has been linked to altered glutamate neurotransmission and excitotoxicity (3739) as well as dysregulation of monoamines (dopamine, serotonin, norepinephrine) (35, 40, 41) and reduced neurotrophic support, particularly decreased BDNF, a key molecule for synaptic plasticity and neuronal survival (4143)
With obesity trials ongoing and an FDA-approval for this indication looming, analysts have predicted peak sales to balloon to a staggering $25B
If youre new to GLP-1 therapy or want guidance on whats best for you, talking with a licensed provider can ensure your approach makes sense for you and your circumstances
The assessment of plasma lipid peroxidation markers, including F2-isoprostanes, F2-dihomo-isoprostanes, and F4-neuroprostanes, revealed increased levels of lipid peroxidation in the T21 group (Manna et al
What the violations mean for patient safety Theoretical risk and actual risk are different things
Effectiveness: Metformin can cause some weight loss, although not as much as the GLP-1 drugs